Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous HMR4396 for anaemia in chronic renal failure
ISRCTN68321818Phase 3Completed
- Sponsor
- Hoechst Marion Roussel (Shire Pharmaceuticals) (France)
- Start
- Oct 1998
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
01
Overview
Phase 3, open-label trial of epoetin delta in Uraemic Anaemia (3 arms), sponsored by Hoechst Marion Roussel (Shire Pharmaceuticals) (France). Primary endpoint: Average haemoglobin concentration. Started Oct 1998; status: completed.
02
Drugs
epoetin delta
03
Conditions
Uraemic Anaemia
Beyond the preview
Go deeper on ISRCTN68321818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN68321818.